• Product nameAnti-RSK3 antibody [E202]
    See all RSK3 primary antibodies
  • Description
    Rabbit monoclonal [E202] to RSK3
  • SpecificityThis antibody will detect total RSK3.
  • Tested applicationsSuitable for: WB, IHC-P, ICC, IPmore details
    Unsuitable for: Flow Cyt
  • Species reactivity
    Reacts with: Mouse, Rat, Human
  • Immunogen

    A synthetic phospho-peptide corresponding to residues surrounding Thr353 and Thr356 of human RSK3.

  • Positive control
    • Human prostate carcinoma tissue.
  • General notes

    This product is a recombinant rabbit monoclonal antibody.

    Produced using Abcam’s RabMAb® technology. RabMAb® technology is covered by the following U.S. Patents, No. 5,675,063 and/or 7,429,487.



Our Abpromise guarantee covers the use of ab32563 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
WB 1/20000. Predicted molecular weight: 83 kDa.
IHC-P 1/50 - 1/100.
ICC 1/50.
IP 1/100.
  • Application notesIs unsuitable for Flow Cyt.
  • Target

    • FunctionSerine/threonine-protein kinase that acts downstream of ERK (MAPK1/ERK2 and MAPK3/ERK1) signaling and mediates mitogenic and stress-induced activation of transcription factors, regulates translation, and mediates cellular proliferation, survival, and differentiation. May function as tumor suppressor in epithelial ovarian cancer cells.
    • Tissue specificityWidely expressed with higher expression in lung, skeletal muscle, brain, uterus, ovary, thyroid and prostate.
    • Sequence similaritiesBelongs to the protein kinase superfamily. AGC Ser/Thr protein kinase family. S6 kinase subfamily.
      Contains 1 AGC-kinase C-terminal domain.
      Contains 2 protein kinase domains.
    • Post-translational
      Activated by phosphorylation at Ser-218 by PDPK1. Autophosphorylated on Ser-377, as part of the activation process. May be phosphorylated at Thr-356 and Ser-360 by MAPK1/ERK2 and MAPK3/ERK1.
      N-terminal myristoylation results in an activated kinase in the absence of added growth factors.
    • Cellular localizationNucleus. Cytoplasm.
    • Information by UniProt
    • Database links
    • Alternative names
      • 90 kDa ribosomal protein S6 kinase 2 antibody
      • HU 2 antibody
      • KS6A2_HUMAN antibody
      • MAP kinase activated protein kinase 1c antibody
      • MAP kinase-activated protein kinase 1c antibody
      • MAPK-activated protein kinase 1c antibody
      • MAPKAP kinase 1c antibody
      • MAPKAPK-1c antibody
      • MAPKAPK1C antibody
      • Mitogen.activated protein kinase-activated protein kinase 1C antibody
      • p90 RSK3 antibody
      • p90-RSK 2 antibody
      • p90RSK2 antibody
      • pp90RSK3 antibody
      • Ribosomal protein S6 kinase alpha-2 antibody
      • ribosomal protein S6 kinase, 90kDa, polypeptide 2 antibody
      • Ribosomal S6 kinase 3 antibody
      • RPS6KA2 antibody
      • RSK 3 antibody
      • RSK antibody
      • RSK-3 antibody
      • S6K alpha antibody
      • S6K alpha 2 antibody
      • S6K-alpha-2 antibody
      see all

    Anti-RSK3 antibody [E202] images

    • Immunohistochemical analysis of paraffin-embedded human prostate carcinoma using ab32563 at 1/50 dilution.

    References for Anti-RSK3 antibody [E202] (ab32563)

    ab32563 has not yet been referenced specifically in any publications.

    Product Wall

    There are currently no Abreviews or Questions for ab32563.
    Please use the links above to contact us or submit feedback about this product.